arrow
C

Christopher Szeto

La Trobe University
H指数:24
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular determinants of cross-strain influenza A virus recognition by αβ T cell receptors

αβ T细胞受体跨菌株识别甲型流感病毒的分子决定因素

2025-02-210
PRE
Type I interferons induce an epigenetically distinct memory B cell subset in chronic viral infection
IMMUNITY
IF26.3
2024-05-013
PRE
Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan

老年人的新生儿和儿童样分子特征源于人类寿命的TCR变化

2023-09-257
OAAI
HLA-A*11:01-restricted CD8+ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous people

Hla-a * 11:01限制性CD8 T细胞对土著和非土著人群甲型和乙型流感病毒的免疫

2022-03-0719
OAAI
CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph
2021-05-1827
OAAI
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses

特异于免疫优势SARS-CoV-2核衣壳表位的CD8 T细胞与选择性季节性冠状病毒交叉反应

IMMUNITY
IF26.3
2021-05-01132
OAAI
Landscape of immune-cell signatures in early high-risk breast cancer (BC) reveals clinically-relevant enrichment of immune subpopulations
2020-02-150
PRE
Caveolin gene expression predicts for response and clinical outcomes of patients treated with preoperative paclitaxel-based chemotherapy regimens in early stage breast cancer
2020-02-150
PRE
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition (vol 24, pg 968, 2018)
2018-08-093
OAAI
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
2018-05-28219
OAAI